Sep 23, 2026
Explore topics

Dexcom Stelo vs Abbott Lingo: Which OTC CGM Is Right for You

Compare Dexcom Stelo vs Abbott Lingo, two OTC CGM devices. Learn about accuracy, cost, features, and compatibility to choose the right monitor for your needs.

Maren AlcottMaren Alcott
· Sep 23, 2026· 15 min read
Comparison of Dexcom Stelo and Abbott Lingo CGM devices.

Introduction

Dexcom Stelo vs Abbott Lingo are two over-the-counter continuous glucose monitors that have transformed access to glucose tracking for people managing prediabetes, type 2 diabetes, or wanting to understand how food and activity affect their glucose levels. Unlike prescription CGMs, these devices are available directly to consumers without a doctor's order. Continuous glucose monitors (CGMs) are small, wearable devices that continuously measure glucose levels using a tiny sensor under the skin, providing real-time data and trend information that fingerstick meters cannot capture.

The arrival of Dexcom Stelo and Abbott Lingo in the OTC market gives consumers two distinct options, each with its own approach to glucose monitoring. Both devices promise convenience and insight, but they differ in sensor wear time, app functionality, data presentation, and price structure. For someone newly exploring CGM technology—or transitioning from fingerstick testing—understanding these differences is essential to making an informed choice.

This comparison examines Dexcom Stelo vs Abbott Lingo across the dimensions that matter most: how each device works, what the data looks like in the app, what you'll pay, and who should choose which system. The goal is to provide a clear, evidence-based guide so you can select the OTC CGM that aligns with your needs and preferences.

Overview of Dexcom Stelo

Dexcom Stelo made history as the first over-the-counter continuous glucose monitor cleared by the FDA in March 2024, with devices shipping to customers starting August 26, 2024. Designed for adults 18 and older with diabetes who do not use insulin, Stelo offers a 15-day wear period per sensor — a straightforward approach to tracking glucose trends without needing a prescription or insurance authorization.

The device integrates with multiple health platforms, including Oura, Apple Health, and Google Fit, giving users flexibility in how they view and share their glucose data. This broad compatibility sets Stelo apart in the OTC CGM category, particularly for users who already track metrics like sleep, activity, or heart rate through wearable devices. The Dexcom Clarity app provides detailed historical reports, allowing users to analyze long-term patterns and spot trends that might not be obvious from day-to-day readings.

Key Features of Dexcom Stelo

Stelo's design emphasizes simplicity and integration. The sensor applies to the back of the upper arm and transmits glucose readings to your smartphone every few minutes. No fingerstick calibration is required, and the device is water-resistant for everyday activities including showering and swimming.

  • 15-day wear time — each sensor lasts just over two weeks before replacement
  • Multi-platform integration — syncs with Oura, Apple Health, Google Fit, and the Dexcom Clarity app
  • No prescription required — available for direct purchase as an OTC device
  • Real-time glucose tracking — continuous readings throughout the day and night
  • Historical trend analysis — Clarity app provides detailed reports for pattern recognition

The Clarity app is particularly useful for users who want to understand how meals, activity, sleep, or stress affect their glucose levels over weeks or months. Rather than reacting to single readings, you can identify recurring patterns — for instance, whether your glucose tends to spike after breakfast or dip overnight — and bring those observations to your next appointment.

For users new to continuous glucose monitoring, Stelo's integration with familiar health apps can ease the learning curve. If you already check your Oura ring for sleep data or log workouts in Apple Health, adding glucose trends to that same ecosystem creates a more complete picture of your metabolic health. The device does not provide predictive alerts or alarms — it shows your current glucose and recent trend, but it won't warn you before a high or low occurs.

Overview of Abbott Lingo

Abbott Lingo is positioned differently from most continuous glucose monitors: it's designed for people without diabetes who want to understand how their daily habits affect their glucose patterns. Rather than serving as a medical device for managing a diagnosed condition, Lingo functions as a wellness and educational tool — a way to see what happens after a meal, a workout, or a night of poor sleep, and to build habits around those observations.

Who Abbott Lingo Is For

Lingo targets a wellness-focused audience. If you don't have diabetes but want insight into your metabolic responses — perhaps you're curious about how certain foods spike your glucose, or you're working on weight management and energy stability — Lingo offers a structured way to track and learn. It's not intended for diagnosis or medical decision-making; instead, it's built to educate and guide behavior change over time.

Key Features and the Lingo Count Metric

Each Lingo sensor is worn for 14 days, similar to other CGM devices. What sets Lingo apart is its proprietary Lingo Count metric, which simplifies glucose data into a daily score based on the number and size of glucose spikes you experience. Rather than asking you to interpret raw glucose traces, Lingo translates your day into a single number and pairs it with personalized coaching prompts in the app.

The app also delivers bite-sized coaching based on your patterns — suggestions for meal timing, activity adjustments, or stress management — tailored to the spikes and trends it observes in your data. For users who want guidance without diving into the technical details of glucose curves, this approach can feel more approachable than a traditional CGM interface.

User Experience and Practical Considerations

Because Lingo is marketed as a wellness device, the onboarding and app experience emphasize education and habit formation rather than medical alerts or thresholds. You won't receive urgent low-glucose alarms, because the system assumes you're not managing insulin or a condition that requires real-time intervention. Instead, the focus is on retrospective learning: reviewing your day, identifying what caused a spike, and experimenting with changes.

The 14-day wear period matches the industry standard for disposable sensors, and users report that application is straightforward. The sensor adheres to the back of the upper arm, and the app syncs data continuously via Bluetooth. For someone new to glucose monitoring, the interface is designed to feel less clinical and more like a fitness tracker — approachable, visual, and oriented toward incremental improvement.

Limitations to Keep in Mind

Lingo's wellness framing is both a strength and a boundary. If you have diabetes — type 1, type 2, or gestational — or if you're managing prediabetes with medication, Lingo is not the right tool. It lacks the medical-grade features, alert thresholds, and integration with care teams that a prescription CGM or a diabetes-focused OTC device would provide. The coaching is generalized and based on population patterns, not individualized medical advice, so it cannot replace guidance from your endocrinologist or diabetes educator.

Additionally, because Lingo is newer to the OTC CGM market, real-world accuracy data and independent clinical validation are still emerging. The device uses the same core sensor technology as Abbott's FreeStyle Libre line, which has a strong track record, but the Lingo-specific algorithms and coaching features are proprietary and less extensively studied in peer-reviewed literature.

If you're comparing Lingo to a device like Dexcom Stelo — which is cleared for people with diabetes and includes medical-context features — the distinction is fundamental: Lingo is for learning and wellness, while Stelo is for managing a diagnosed condition. Choosing between them depends entirely on whether you need a medical tool or an educational one.

Dexcom Stelo vs Abbott Lingo: Feature Comparison

When choosing between Dexcom Stelo and Abbott Lingo, understanding how their core features stack up helps you match the device to your monitoring goals. Both systems offer over-the-counter glucose tracking without fingersticks, but they differ in sensor longevity, accuracy specifications, and the data presentation that shapes your day-to-day experience.

Sensor Wear Time and Replacement Schedule

Dexcom Stelo sensors last 15 days plus a 12-hour grace period before replacement, giving you just over two weeks of continuous wear per sensor. Abbott Lingo sensors run for 14 days with no documented grace window. The extra day on Stelo can simplify subscription logistics—fewer sensors per month means one less box to track—but both systems require you to plan ahead for sensor swaps to avoid gaps in your glucose data.

Accuracy: MARD Specifications

Mean Absolute Relative Difference (MARD) measures how closely a CGM's readings match laboratory reference values; lower percentages indicate tighter accuracy. Dexcom Stelo reports a MARD of approximately 8.3%, while Abbott Lingo's published MARD is around 9.3%. In practical terms, both fall within the range considered clinically acceptable for over-the-counter use, but Stelo's slightly lower MARD suggests it may track closer to a fingerstick meter result on average. Individual performance can vary with factors like hydration, sensor placement, and how your body responds to the adhesive and filament.

Data Presentation and App Experience

Both devices deliver real-time glucose readings to a smartphone app, but the interface and coaching features differ. User feedback on Stelo often highlights its straightforward trend graphs and integration with Dexcom's established app ecosystem, which some find easier to navigate if they've used prior Dexcom systems. Lingo's app emphasizes personalized insights and glucose-pattern coaching, aiming to help users connect meals, activity, and sleep to their glucose curves. If you prefer data-driven dashboards with minimal interpretation, Stelo's presentation may feel more direct; if you want the app to surface patterns and suggest behavior adjustments, Lingo's coaching layer can add context—though some users report the guidance feels repetitive after the first few weeks.

Pros and Cons Based on User Feedback

Dexcom Stelo strengths: Longer wear time reduces the hassle of frequent sensor changes; tighter MARD spec appeals to users who cross-check with fingerstick meters; familiar Dexcom app interface for those migrating from prescription CGMs.

Dexcom Stelo limitations: Slightly higher monthly cost at scale (see Pricing and Availability); fewer in-app coaching prompts may leave new users wanting more interpretation help.

Abbott Lingo strengths: Lower trial price makes it easier to test CGM tracking before committing; app's coaching features can accelerate learning for first-time CGM users; established Abbott sensor technology from the FreeStyle Libre line.

Abbott Lingo limitations: One-day-shorter sensor life means more frequent replacements; marginally higher MARD may result in occasional readings that diverge from fingerstick checks.

Choosing between these systems often comes down to whether you prioritize the longest possible wear time and the tightest accuracy spec (Stelo) or a lower entry price and more hands-on app guidance (Lingo). Both deliver the core benefit of seeing your glucose in real time; the differences lie in the details of how you interact with that data day to day.

Pricing and Availability

Both Dexcom Stelo and Abbott Lingo are sold over-the-counter without a prescription, but their pricing structures and where you can buy them differ in ways that may affect your decision.

Subscription Costs and Trial Options

Dexcom Stelo is priced at $99 per month for two sensors, with each sensor lasting 15 days. This works out to continuous coverage for a 30-day period. Abbott Lingo offers a two-week trial for $49, which lets you test the system before committing to a longer subscription. After the trial, Lingo's ongoing pricing varies, but the lower entry point makes it easier to try the device without a significant upfront investment.

Neither device is currently covered by most insurance plans because they are classified as wellness products rather than medical devices. If you have diabetes and use insulin, a prescription CGM like Dexcom G7 or FreeStyle Libre 3 may be covered by insurance — check with your care team about medical-grade options if cost is a barrier.

Where to Buy

Dexcom Stelo is primarily sold online through Dexcom's direct-to-consumer website. Abbott Lingo, positioned as a wellness product, is available in more retail locations in addition to online purchase. This broader retail presence may make Lingo more accessible if you prefer to pick up sensors in person or want immediate availability without waiting for shipping.

If you need a device for diabetes care — especially if you take insulin or have been diagnosed with type 1, type 2, or gestational diabetes — neither Stelo nor Lingo replaces a prescription CGM. Both are intended for people without diabetes who want to understand how food, activity, and sleep affect their glucose patterns.

Final Verdict

Choosing between Dexcom Stelo and Abbott Lingo depends on what you need from a continuous glucose monitor and how you plan to use it. Both devices offer over-the-counter access to glucose tracking without a prescription, but they serve slightly different purposes and user preferences.

Which Device Should You Choose?

For most people exploring glucose monitoring for the first time, Abbott Lingo offers the easiest entry point. Its lower upfront cost — a single biosensor starts at $49 — makes it less intimidating to try. The coaching-focused app walks you through interpreting your data without overwhelming you with continuous alerts. If you want to learn how your meals, activity, and sleep affect your glucose without committing to a subscription, Lingo is the practical choice.

Dexcom Stelo becomes the stronger option once you know you want ongoing, continuous data. Its 15-day wear time, real-time alerts, and integration with health platforms like Apple Health give you more control and fewer sensor changes. If you're managing prediabetes or type 2 diabetes and need consistent feedback to guide daily decisions, Stelo's continuous monitoring justifies the higher monthly cost.

Neither device replaces medical advice or diagnostic testing. If your glucose readings reveal patterns that concern you — frequent highs, unexpected lows, or wide swings — bring that data to your care team. They can interpret the trends in the context of your full health picture and adjust your treatment plan if needed.

Final Recommendation

Stelo is the stronger overall choice for long-term glucose monitoring, but Lingo is easier to try without a large upfront commitment. Your decision comes down to whether you prioritize low-cost exploration or continuous, actionable data. Both devices deliver accurate glucose tracking; the right one depends on how you plan to use the information.

Frequently Asked Questions: Dexcom Stelo vs Abbott Lingo

What is the main difference between Dexcom Stelo and Abbott Lingo?

Dexcom Stelo is designed for adults with diabetes who do not use insulin, offering 15-day sensor wear and real-time glucose tracking. Abbott Lingo is a wellness device for people without diabetes, focusing on education and habit formation with a 14-day sensor and proprietary Lingo Count coaching metric.

Which OTC CGM is more accurate?

Dexcom Stelo reports a MARD of approximately 8.3%, while Abbott Lingo's MARD is around 9.3%. Both fall within clinically acceptable ranges for over-the-counter use, but Stelo's lower MARD indicates slightly tighter accuracy on average.

Do I need a prescription for Dexcom Stelo or Abbott Lingo?

No. Both Dexcom Stelo and Abbott Lingo are over-the-counter devices available without a prescription. However, if you use insulin or have type 1 diabetes, you need a prescription CGM with advanced alerts and integration features.

How much do Dexcom Stelo and Abbott Lingo cost?

Dexcom Stelo costs $99 per month for two sensors (15 days each). Abbott Lingo offers a two-week trial for $49, with ongoing pricing varying after the trial period. Neither device is typically covered by insurance as they are classified as wellness products.

Can I use these devices if I have diabetes and take insulin?

No. Both Dexcom Stelo and Abbott Lingo are designed for adults who do not use insulin. If you take insulin or have type 1 diabetes, consult your care team about prescription CGM options like Dexcom G7 or FreeStyle Libre 3.

Compass Reading — weekly orientation

One short letter a week — what to read, what to ask your care team, what to skip. Calm, sourced, free.

Subscribe — it's free